You may also like
Complement Suppression Drug Does Not Prevent Cognitive Decline After CABG
Treatment with pexelizumab, a monoclonal antibody against the C5 complement component, does not prevent the overall drop in cognition that can occur after coronary artery bypass grafting (CABG), new research shows.
Cardiac Blood Flow & O2 Consumption v1.0
Cardiac Blood Flow & O2 Consumption Source: Cardiovascular Physiology Concepts Richard E. Klabunde, PhD The major vessels of the coronary circulation […]
ECMO Membrane Lung Failure due to Hypertriglyceridemia: A Case Report and Review of the Literature
Hypertriglyceridemia should be suspected in patients with high transmembrane pressures and ML failure not attributable to thrombosis, and these patients may require frequent ML changes if a prolonged ECMO run is required.